Clinical Trial Update: Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

View source ↗

Summary

Sponsored by Kernel, the TD-fNIRS trial investigating Mild Cognitive Impairment in patients and controls has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Kernel | Conditions: Mild Cognitive Impairment | Status: COMPLETED